Trastuzumab Emtansine (T-DM1)*
- FLASCO
- March 10, 2015
- Drugs
Trastuzumab Emtansine (T-DM1)*
ASCO® Clinical Oncology Practice Guidelines recommend trastuzumab emtansine (T-DM1)* as second-line therapy for advanced HER2+ breast cancer1,2. For complete information, please click here.
